TEMSIROLIMUS for Sarcoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where TEMSIROLIMUS was used for Sarcoma.
Most Reported Side Effects for TEMSIROLIMUS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 158 | 9.6% | 66 | 50 |
| Death | 136 | 8.3% | 135 | 14 |
| Stomatitis | 100 | 6.1% | 17 | 51 |
| Anaemia | 89 | 5.4% | 16 | 44 |
| Neoplasm progression | 84 | 5.1% | 33 | 24 |
| Vomiting | 81 | 4.9% | 13 | 52 |
| Diarrhoea | 79 | 4.8% | 9 | 51 |
| Febrile neutropenia | 78 | 4.7% | 1 | 66 |
| Pneumonia | 76 | 4.6% | 23 | 52 |
| Off label use | 75 | 4.6% | 15 | 12 |
| Fatigue | 74 | 4.5% | 15 | 25 |
| Pyrexia | 73 | 4.4% | 11 | 52 |
| Dehydration | 69 | 4.2% | 4 | 62 |
| Thrombocytopenia | 62 | 3.8% | 15 | 21 |
| Dyspnoea | 59 | 3.6% | 16 | 27 |
Other Indications for TEMSIROLIMUS
Renal cell carcinoma (213)
Metastatic renal cell carcinoma (131)
Embryonal rhabdomyosarcoma (121)
Product used for unknown indication (88)
Renal cancer (69)
Mantle cell lymphoma (65)
Neoplasm malignant (60)
Rhabdomyosarcoma (51)
Alveolar rhabdomyosarcoma (38)
Metastatic malignant melanoma (35)
Other Drugs Used for Sarcoma
DOXORUBICIN (409)
PAZOPANIB (296)
IFOSFAMIDE (280)
EPIRUBICIN (132)
NIVOLUMAB (124)
VINCRISTINE (105)
CYCLOPHOSPHAMIDE (79)
ETOPOSIDE (75)
TRABECTEDIN (75)
TRONOXAL INYECTABLE (74)